Media & Advertising
Glaxosmithkline Plc and Genmab A/S Announce Positive Top-Line Results From Pivotal
Have an interest in this Story?
Sign Up for Real-Time email updates
May 29, 2013
6:16pm BST Genmab A/S and Glaxosmithkline Plc announced that their Phase III study of ARZERRA (ofatumumab) in combination with chlorambucil versus chlorambucil alone in patients with previously untreated chronic lymphocytic leukemia (CLL) met its primary endpoint of progression free survival (PFS) a...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Most Read Biotech Articles
Economy adds 175,000 jobs in February, despite harsh weather [The Philadelphia Inquirer
Infotech acquires US-based Softential
- Yahoo! India
Obama calls world leaders about Ukraine
Obama administration defends cuts on nuclear security (USA TODAY)
- WHBY AM 1150
President Barack Obama to Introduce Series Premiere of Cosmos!
- Eclipse Magazine
Sergio Waldeck, MBA
Director of Financial Planning and Analysis
Sylvia M. Romagosa, MBA
Licensed Real Estate Broker
Real Estate Industry
View more profiles
Access dozens of premium and subscriptions sites
Build a News Circle
Get News Briefings
Congoo News Home
Get the Netpass
Copyright ©2014 Congoo.com. All Rights Reserved.